Early research (Phase 1)Study completedNCT06573281
What this trial is testing
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 213